CTRI/2023/01/048770尚未招募4 期
Comparison of treatment efficacy of Mirabegron with alpha-blockers versus Mirabegron alone in patients of Parkinsons Disease with lower urinary tract symptoms: A Randomized Controlled Trial
DEPARTMENT OF UROLOGY KASTURBA MEDICAL COLLEGE MANIPA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients with Parkinson disease having moderate/bothersome LUTS as per IPSS questionnaire
排除标准
- •1. Montreal Cognitive Assessment score <24,
- •2. Poorly controlled diabetes or poorly controlled hypertension ,
- •3. Indwelling catheter,
- •4. Renal dialysis
- •5. Cardiac failure requiring diuretics
- •6. Urinary tract infection at presentation
- •7. Prostate or bladder cancer
- •8. Uncontrolled bladder outlet obstruction
研究者
相似试验
尚未招募
4 期
Comparing the efficacy of Mirabegron in reducing urinary symptoms associated with cerebrovascular accidentsCTRI/2023/03/050511DEPARTMENT OF UROLOGY KASTURBA MEDICAL COLLEGE MANIPA
招募中
4 期
Comparison of vibegron and mirabegron in the treatment of female over active bladder subjects: A randomized, prospective studyoveractive bladderJPRN-UMIN000038288Department of urology, Hokusuikai Kinen Hospital100
已完成
不适用
Examination the efficacy of Mirabegron on patient with overactive bladder after treatment with a1 blocker for benign prostatic hyperplasiaOveractive bladderJPRN-UMIN000019735Department of Urology, Shiga University of medical Science20
招募中
4 期
Safety and efficacy of mirabegron on nocturia and quality of sleep in Japanese patients with overactive bladder.overactive bladderJPRN-UMIN000012869Fujita Health University100
已完成
不适用
Comparison of Mirabegron and Imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT Study).Overactive bladderJPRN-UMIN000010321Department of Urology, Hamamatsu University School of Medicine200